Genertec Universal Medical Group Company Limited logo

Genertec Universal Medical Group Company Limited

2666.HK

HKSEFinancial ServicesFinancial - Credit Services

Latest quote

HK$4.605

−HK$0.065 · -1.39%

Aug 24, 4:08 PM HKT

2666.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Genertec Universal Medical Group Company Limited, founded in 1984 and based in Beijing, China, provides extensive financing and advisory services across the People's Republic of China, alongside operating a significant healthcare business. The company's operations are segmented into two primary divisions. The Finance and Advisory segment delivers a range of services including direct finance leasing, sale-and-leaseback arrangements, factoring, operating leases, and various advisory offerings. Meanwhile, its Hospital Group segment focuses on providing medical care, managing hospitals and healthcare facilities, and conducting import, export, and general trading of medical-related goods. Beyond these core areas, Genertec Universal Medical also engages in medical technology development, hospital digitalization, construction, and management services, as well as property management and medical consulting. The company serves a diverse clientele, encompassing patients, hospitals, medical equipment suppliers, and other public sector organizations. In July 2018, the company adopted its current name, having previously operated as Universal Medical Financial & Technical Advisory Services Company Limited.

Industry
Financial - Credit Services
Sector
Financial Services
Headquarters
CN
CEO
Qi Xia
Listed since
Jul 8, 2015
Employees
23,791

Market position

Day range

Current HK$4.605

52-week range

Current HK$4.605

Open
HK$4.68
Previous close
HK$4.67
Volume
3.61M
0.74× average
Average volume
4.85M
Average daily volume
Market cap
9.28B HKD
Beta
0.59
Market reference 1
50-day average
HK$4.7247
-2.53% below average
200-day average
HK$5.681
-18.94% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
58.34B CNY
P/E (TTM)
3.49×
P/B (TTM)
0.42×
P/S (TTM)
0.55×
EV / EBITDA
15.05×
Earnings yield
20.26%
Free cash flow yield
28.28%
Dividend yield
7.82%

Profitability & efficiency

Gross margin
100.00%
Operating margin
58.56%
Net margin
15.19%
Return on equity
11.45%
Return on assets
2.62%
Return on invested capital
11.52%

Financial health

Debt / equity
2.6×
Current ratio
3.64×
Altman Z-score
1.65
Piotroski F-score
7 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends110%76%41%7%Gross margin, FY2021: 100.00%Gross margin, FY2022: 101.42%Gross margin, FY2023: 33.49%Gross margin, FY2024: 33.61%Gross margin, FY2025: 34.81%Operating margin, FY2021: 87.17%Operating margin, FY2022: 89.29%Operating margin, FY2023: 23.68%Operating margin, FY2024: 22.59%Operating margin, FY2025: 87.06%Net margin, FY2021: 20.36%Net margin, FY2022: 16.94%Net margin, FY2023: 15.46%Net margin, FY2024: 15.40%Net margin, FY2025: 15.19%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 100.00%. Gross margin FY2022 101.42%. Gross margin FY2023 33.49%. Gross margin FY2024 33.61%. Gross margin FY2025 34.81%. Operating margin FY2021 87.17%. Operating margin FY2022 89.29%. Operating margin FY2023 23.68%. Operating margin FY2024 22.59%. Operating margin FY2025 87.06%. Net margin FY2021 20.36%. Net margin FY2022 16.94%. Net margin FY2023 15.46%. Net margin FY2024 15.40%. Net margin FY2025 15.19%.

Income trends

Revenue

14.54B CNY+6.41%

Operating income

12.66B CNY+310.06%

Net income

2.21B CNY+4.99%
Income trends across reported periods15.8B CNY10.76B CNY5.73B CNY688.62M CNYRevenue, FY2021: 9.57B CNYRevenue, FY2022: 11.57B CNYRevenue, FY2023: 13.65B CNYRevenue, FY2024: 13.66B CNYRevenue, FY2025: 14.54B CNYOperating income, FY2021: 8.34B CNYOperating income, FY2022: 10.33B CNYOperating income, FY2023: 3.23B CNYOperating income, FY2024: 3.09B CNYOperating income, FY2025: 12.66B CNYNet income, FY2021: 1.95B CNYNet income, FY2022: 1.96B CNYNet income, FY2023: 2.11B CNYNet income, FY2024: 2.1B CNYNet income, FY2025: 2.21B CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 9.57B CNY. Revenue FY2022 11.57B CNY. Revenue FY2023 13.65B CNY. Revenue FY2024 13.66B CNY. Revenue FY2025 14.54B CNY. Operating income FY2021 8.34B CNY. Operating income FY2022 10.33B CNY. Operating income FY2023 3.23B CNY. Operating income FY2024 3.09B CNY. Operating income FY2025 12.66B CNY. Net income FY2021 1.95B CNY. Net income FY2022 1.96B CNY. Net income FY2023 2.11B CNY. Net income FY2024 2.1B CNY. Net income FY2025 2.21B CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue14.54B CNY13.66B CNY13.65B CNY11.57B CNY9.57B CNY
Cost of goods sold9.59B CNY9.07B CNY9.08B CNY7.58B CNY5.71B CNY
Gross profit5.06B CNY4.59B CNY4.57B CNY11.73B CNY9.57B CNY
Research and development77.66M CNY66.78M CNY35.88M CNY48.07M CNY25.84M CNY
Selling, general, and administrative1.8B CNY1.71B CNY1.57B CNY1.36B CNY1.2B CNY
Operating expenses552.67M CNY1.51B CNY1.34B CNY1.15B CNY990.25M CNY
Interest income41.94M CNY55.51M CNY84.13M CNY73.96M CNY56.7M CNY
Interest expense69.35M CNY50.71M CNY39.05M CNY35.32M CNY29.13M CNY
Depreciation and amortization788.46M CNY602.26M CNY508.67M CNY442.05M CNY319.46M CNY
Operating income12.66B CNY3.09B CNY3.23B CNY10.33B CNY8.34B CNY
Net income2.21B CNY2.1B CNY2.11B CNY1.96B CNY1.95B CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
0%
0 beats, 4 misses, 0 met estimates
Average EPS surprise
-53.27%
4 comparable reports
Latest EPS result
0.53

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.381.050.710.38Q4 '22MissQ1 '23MissQ3 '23No estimateQ3 '24No estimateQ4 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q4 2022, reported Oct 28, 2022: actual 0.62, estimate 1.31, surprise -52.67%, Miss. Q1 2023, reported Mar 29, 2023: actual 0.444, estimate 1.31, surprise -66.09%, Miss. Q3 2023, reported Aug 23, 2023: actual 0.573, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 28, 2024: actual 0.612, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Oct 31, 2024: actual 0.591, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual 0.5, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 27, 2025: actual 0.679, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 25, 2026: actual 0.534, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates19.24B14.68B10.12B5.57BQ4 '22MissQ1 '23MissQ3 '23MissQ3 '24MissQ4 '24No estimateQ1 '25MissQ3 '25No estimateQ1 '26No estimate
Q4 2022, reported Oct 28, 2022: actual 6.51B HKD, estimate 13.2B HKD, surprise -50.67%, Miss. Q1 2023, reported Mar 29, 2023: actual 7.02B HKD, estimate 16.91B HKD, surprise -58.49%, Miss. Q3 2023, reported Aug 23, 2023: actual 7.17B HKD, estimate 16.95B HKD, surprise -57.70%, Miss. Q3 2024, reported Aug 28, 2024: actual 7.03B HKD, estimate 18.3B HKD, surprise -61.58%, Miss. Q4 2024, reported Oct 31, 2024: actual 6.89B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual 7.36B HKD, estimate 8.21B HKD, surprise -10.36%, Miss. Q3 2025, reported Aug 27, 2025: actual 8.31B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 25, 2026: actual 7.83B HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.35

2025 complete year+12.9% since 2021

2026 partial: HK$0.36

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jun 26, 2026

HK$0.36

Annual

Record Jun 30, 2026 · Payment Jul 15, 2026

Dividend

Ex-dividend Jun 12, 2025

HK$0.35

Annual

Record Jun 14, 2025 · Payment Jun 27, 2025

Dividend

Ex-dividend Jun 12, 2024

HK$0.35

Annual

Record Jun 13, 2024 · Payment Jul 30, 2024

Dividend

Ex-dividend Jun 9, 2023

HK$0.34

Annual

Record Jun 12, 2023 · Payment Jun 27, 2023

Dividend

Ex-dividend Jun 9, 2022

HK$0.36

Annual

Record Jun 10, 2022 · Payment Jun 27, 2022

Dividend

Ex-dividend Jun 10, 2021

HK$0.31

Annual

Record Jun 11, 2021 · Payment Jun 28, 2021

2666.HK peers

ETFs holding 2666.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 2666.HK

research.disclaimer